| Symbol | Company | Owner | Relationship | Date | Transaction | Cost | # Shares | Value ($) | Total Shares | Filing | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| LGND | LIGAND PHARMACEUTICALS INC | Espinoza Octavio | Chief Financial Officer | Feb 28, 2024 | Option Exercise | $56.62 | 1,264 | 71,564 | 29,895 | Feb 29, 2024, 06:50 PM | |
| LGND | LIGAND PHARMACEUTICALS INC | Espinoza Octavio | Chief Financial Officer | Feb 28, 2024 | Sale | $88.46 | 140 | 12,384 | 29,755 | Feb 29, 2024, 06:50 PM | |
| LGND | LIGAND PHARMACEUTICALS INC | Espinoza Octavio | Chief Financial Officer | Feb 15, 2024 | Option Exercise | $74.65 | 1,479 | 110,407 | 21,423 | Feb 16, 2024, 08:10 PM | |
| LGND | LIGAND PHARMACEUTICALS INC | Espinoza Octavio | Chief Financial Officer | Dec 05, 2023 | Option Exercise | $59.61 | 1,269 | 75,645 | 22,902 | Dec 06, 2023, 03:27 PM | |
| LGND | LIGAND PHARMACEUTICALS INC | Espinoza Octavio | Chief Financial Officer | Oct 01, 2023 | Option Exercise | $59.92 | 346 | 20,732 | 24,171 | Oct 03, 2023, 04:36 PM | |
| LGND | LIGAND PHARMACEUTICALS INC | Espinoza Octavio | Chief Financial Officer | Jun 30, 2023 | Option Exercise | $56.78 | 375 | 21,292 | 24,517 | Jul 10, 2023, 06:42 PM | |
| LGND | LIGAND PHARMACEUTICALS INC | Espinoza Octavio | Chief Financial Officer | Feb 15, 2023 | Option Exercise | $72.98 | 849 | 61,960 | 18,096 | Feb 17, 2023, 07:20 PM | |
| LGND | LIGAND PHARMACEUTICALS INC | Espinoza Octavio | Chief Financial Officer | Dec 30, 2022 | Option Exercise | $56.78 | 275 | 15,614 | 18,945 | Jan 04, 2023, 05:00 PM | |
| LGND | LIGAND PHARMACEUTICALS INC | Espinoza Octavio | Chief Financial Officer | Nov 30, 2022 | Option Exercise | $72.90 | 1,187 | 86,532 | 7,670 | Dec 01, 2022, 09:41 PM | |
| LGND | LIGAND PHARMACEUTICALS INC | Espinoza Octavio | Chief Financial Officer | Nov 09, 2022 | Sale | $75.64 | 1,696 | 128,283 | 8,857 | Nov 10, 2022, 04:30 PM |
Menu